Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study(legacy) | 165 |
| Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study(legacy) | 124 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study | 0 | 5 | 2 | 10 | 1 | 6 | 6 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 127 |
| United States | 64 |
| China | 17 |
| Netherlands | 9 |
| France | 6 |
| Vietnam | 5 |
| Singapore | 3 |
| Germany | 2 |
| Hong Kong SAR China | 2 |
| Lithuania | 2 |
Top City Views
| Views | |
|---|---|
| Kaleen | 72 |
| Ashburn | 24 |
| Fairfield | 11 |
| Rotterdam | 8 |
| Hanoi | 5 |
| Beijing | 3 |
| Cambridge | 2 |
| Central | 2 |
| Chongqing | 2 |
| Singapore | 2 |